1Stratton IM, Adler AI, Neil HAW, et al.Association of glycemia with macrovascular and microvascular complications of Type 2 diabetes: prospective observational smdy(UKPDS35).BMJ, 2000, 321(12):405-412.
2Monnier L,Lapinsbi H,Coletle C,et al.Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations With increasing levels of HbA(lc).Diabetes Care,2003,26(3):881-885.
5Johansen OE,Vanberg PJ,Kihovd BK,et al.Changing basal insulin from NPH to detrmir or glargine in patients with type 1 diabetes and a history of severe hypoglycemia.Vasc health Risk Manag,2009,5(1): 121-128.
6Dorkhan M,Frid A,Grppo L,Differences in effects of insulin glargine or pioglitazone added to oral anti-diabetic therapy in patients with type 2 diabetes:what to add-insulin glargine or pioglitazone.Diabetes Res Clin Pract,2008,82(3):340-345.
